Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes”.
Adriaan H. C. de Jongste, Marienke A.A.M. de Bruijn, Yvette S. Crijnen, Marco W.J. Schreurs, Marcel M. Verbeek +5 more